Loading…
NeoGenomics, Inc. (NEO) Price Prediction 2026–2050
Rank #2066NASDAQBullish
$14.73
+3.44% (24h)
NeoGenomics, Inc. (NEO) Forecast Summary
NeoGenomics, Inc. is projected to rise to $19.85 by 2027, a +35% move from its current price of $14.73. NEO is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Healthcare
Live market data via Yahoo Finance · updated 7/11/2026
Market Cap
$1.92B
24h Volume
$4.07M
Shares Outstanding
130.21M NEO
All-Time High
$198.38
Green Days (30d)
18/30
Volatility (30d)
4.34%
NeoGenomics, Inc. (NEO) Price Prediction Summary
NEO Short-Term Price Forecast
Next 7 days
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 12 | $14.27 | $14.75 | $15.24 | +0.13% |
| Jul 13 | $14.10 | $14.77 | $15.47 | +0.25% |
| Jul 14 | $13.97 | $14.79 | $15.65 | +0.38% |
| Jul 15 | $13.86 | $14.81 | $15.81 | +0.51% |
| Jul 16 | $13.77 | $14.82 | $15.96 | +0.64% |
| Jul 17 | $13.69 | $14.84 | $16.09 | +0.76% |
| Jul 18 | $13.62 | $14.86 | $16.21 | +0.89% |
Next 7 weeks
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $13.62 | $14.86 | $16.21 | +0.89% |
| Week 2 | $13.26 | $14.99 | $16.96 | +1.79% |
| Week 3 | $13.01 | $15.13 | $17.59 | +2.70% |
| Week 4 | $12.82 | $15.26 | $18.17 | +3.62% |
| Week 5 | $12.68 | $15.40 | $18.71 | +4.54% |
| Week 6 | $12.55 | $15.54 | $19.23 | +5.48% |
| Week 7 | $12.45 | $15.68 | $19.74 | +6.42% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
What is NeoGenomics, Inc. (NEO)?
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories.
It also provides cytogenetics testing, fluorescence in-situ hybridization testing, flow cytometry testing, immunohistochemistry and digital imaging testing, as well as molecular testing and morphologic analysis for diagnostic and pharmaceutical oncology programs. The company was founded in 2001 and is headquartered in Fort Myers, Florida.
NeoGenomics sits in the Healthcare sector and provides a broad array of oncology-focused laboratory services, including tests that study chromosomes, DNA and RNA, and tissue morphology to support clinical decision-making and pharmaceutical work. The description emphasizes its role as a networked testing provider with a comprehensive menu of analytical capabilities.
These characteristics position NeoGenomics as a specialized diagnostics company offering laboratory testing services across multiple modalities to a wide range of healthcare and pharmaceutical clients.
NeoGenomics, Inc. launched on October 17, 2016.
NeoGenomics, Inc. Price Prediction Overview
NeoGenomics, Inc. (NEO) is a healthcare diagnostics company currently priced at $14.17 with a market capitalization of $1.85B and a market rank of 2093.
The stock has an all-time high of $198.38 and an all-time low of $0.0783, indicating a very broad historical price range. The near-term outlook shows a neutral to bullish trajectory, with forecasted averages suggesting higher prices over time, culminating in substantial long-term upside.
The forecast shows a path of rising average values from the current level toward multi-year highs, including an average of $24.75 by 2030 and $179.00 by 2050, signaling a pronounced long-term bullish outlook despite near-term variability.
NEO Market & Technical Analysis
NEO Key Price Levels
Strong Support−82.7%
$2.55
A major floor 82.7% below — a decisive break under it would weaken the trend.
Current Support−31.3%
$10.12
The nearest floor, 31.3% below — buyers have tended to step in here.
Current Resistance+2.9%
$15.16
Price is pressing into resistance (2.9% away) — a breakout level to watch.
Strong Resistance+23.4%
$18.17
A major ceiling 23.4% above — clearing it would confirm fresh momentum.
Key NEO support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
NEO Market Analysis
Trend ConsensusBullish
Bullish share of indicators95%
Timeframe AlignmentStrong
Price above 12/12 moving averages100%
Risk AssessmentModerate
~63% annualised volatility52%
Momentum (RSI)Buyers
RSI 63 — buying vs selling pressure63%
A snapshot of NEO market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
NEO Indicator Summary
Strong Buy
Based on 26 indicators
- Buy
- 20
- Neutral
- 5
- Sell
- 1
Bearish95% BullishBullish
Indicators computed on daily closing prices.
Moving Averages
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $14.55 | Buy | $14.43 | Buy |
| MA 10 | $14.59 | Buy | $14.17 | Buy |
| MA 20 | $13.04 | Buy | $13.09 | Buy |
| MA 50 | $8.95 | Buy | $10.05 | Buy |
| MA 100 | $5.86 | Buy | $7.51 | Buy |
| MA 200 | $4.58 | Buy | $6.03 | Buy |
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI (14) | 64.52 | Neutral |
| Stoch RSI (14) | 0.00 | Buy |
| CCI (20) | 44.06 | Neutral |
| Williams %R (14) | -26.52 | Info |
| MACD (12,26,9) | -0.16 | Sell |
| ROC (12) | 23.02 | Buy |
| Bollinger %B (20,2) | 0.66 | Neutral |
| Stochastic %K (14) | 73.48 | Neutral |
| TRIX (15) | 2.57 | Buy |
| Awesome (5,34) | 3.00 | Buy |
| Ultimate (7,14,28) | 54.13 | Neutral |
| Momentum (10) | 0.38 | Buy |
| Aroon Osc (25) | 84.00 | Buy |
| Hull MA (9) | 14.31 | Buy |
| ADX (14) | 39.86 | Buy |
| ATR (14) | 0.49 | Info |
Pivot Levels
- S3$6.06
- S2$8.09
- S1$11.10
- Pivot$13.13
- R1$16.14
- R2$18.17
- R3$21.18
The 30-day technical picture is bullish, as indicated by the sentiment. The RSI14 is 80, and the market’s short-term momentum remains strong relative to recent price action.
The 50-day simple moving average is $9.77 and the 200-day simple moving average is $10.11, with a defined support at $8.24 and a resistance at $14.17. The 30-day price range spans from a low of $11.01 to a high of $18.24, illustrating recent volatility within a tightening corridor.
NeoGenomics, Inc. (NEO) Price Prediction 2026–2050
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $7.19 | $14.73 | $22.71 | 0% | Neutral | |
| $15.50 | $19.85 | $27.07 | +35% | Bullish | |
| $18.01 | $23.86 | $33.98 | +62% | Bullish | |
| $19.94 | $27.19 | $40.05 | +85% | Bullish | |
| $22.11 | $30.93 | $46.85 | +110% | Bullish | |
| $27.54 | $39.44 | $61.22 | +168% | Bullish | |
| $34.31 | $50.22 | $79.68 | +241% | Bullish | |
| $39.61 | $59.18 | $95.78 | +302% | Bullish | |
| $40.25 | $61.32 | $101.07 | +316% | Bullish | |
| $41.46 | $64.36 | $107.88 | +337% | Bullish | |
| $69.18 | $117.08 | $210.52 | +695% | Bullish | |
| $136.40 | $269.01 | $535.24 | +17.3x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
NeoGenomics, Inc. (NEO) 2026 Monthly Forecast
Current Price $14.73Range $7.19 – $22.710% ROI
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $7.19 | $14.73 | $17.93 | +0.00% |
| August 2026 | $13.41 | $15.92 | $19.47 | +8.09% |
| September 2026 | $13.81 | $16.54 | $20.50 | +3.87% |
| October 2026 | $13.71 | $16.54 | $20.72 | -0.01% |
| November 2026 | $14.02 | $17.01 | $21.52 | +2.88% |
| December 2026 | $14.59 | $17.80 | $22.71 | +4.64% |
Click any year to see its month-by-month NEO forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
NeoGenomics, Inc. (NEO) Year-by-Year Price Prediction
NeoGenomics, Inc. (NEO) Price Prediction 2026
By 2026, NEO could reach as high as $22.71, with a base case around $14.73 and support toward $7.19 — roughly 0% from $14.73. A consolidation phase looks the most probable path here.
NeoGenomics, Inc. (NEO) Price Prediction 2027
Expect NEO to range from $15.50 to $27.07 through 2027. The $19.85 average target implies a +35% move from current prices. That is up +35% on the projected 2026 average. Momentum favours further upside here.
NeoGenomics, Inc. (NEO) Price Prediction 2028
The NEO price prediction for 2028 points to an average of $23.86 (low $18.01, high $33.98) — a potential gain of +62% on today's $14.73. Buyers look set to stay in control over this stretch.
NeoGenomics, Inc. (NEO) Price Prediction 2029
In 2029, NEO is projected to trade between $19.94 and $40.05, averaging $27.19 — a potential gain of +85% from today's $14.73. That is up +14% on the projected 2028 average. Momentum favours further upside here.
NeoGenomics, Inc. (NEO) Price Prediction 2030
NeoGenomics, Inc.'s 2030 outlook centres on $30.93, within a $22.11 to $46.85 range. That is up +14% on the projected 2029 average. That marks a +110% change versus current levels. Buyers look set to stay in control over this stretch.
NeoGenomics, Inc. (NEO) Price Prediction 2031
By 2031, NEO could reach as high as $61.22, with a base case around $39.44 and support toward $27.54 — roughly +168% from $14.73. Momentum favours further upside here.
NeoGenomics, Inc. (NEO) Price Prediction 2032
Expect NEO to range from $34.31 to $79.68 through 2032. The $50.22 average target implies a +241% move from current prices. That is up +27% on the projected 2031 average. Buyers look set to stay in control over this stretch.
NeoGenomics, Inc. (NEO) Price Prediction 2033
The NEO price prediction for 2033 points to an average of $59.18 (low $39.61, high $95.78) — a potential gain of +302% on today's $14.73. Momentum favours further upside here.
NeoGenomics, Inc. (NEO) Price Prediction 2034
In 2034, NEO is projected to trade between $40.25 and $101.07, averaging $61.32 — a potential gain of +316% from today's $14.73. That is up +4% on the projected 2033 average. Buyers look set to stay in control over this stretch.
NeoGenomics, Inc. (NEO) Price Prediction 2035
NeoGenomics, Inc.'s 2035 outlook centres on $64.36, within a $41.46 to $107.88 range. That is up +5% on the projected 2034 average. That marks a +337% change versus current levels. Momentum favours further upside here.
NeoGenomics, Inc. (NEO) Price Prediction 2040
By 2040, NEO could reach as high as $210.52, with a base case around $117.08 and support toward $69.18 — roughly +695% from $14.73. Buyers look set to stay in control over this stretch.
NeoGenomics, Inc. (NEO) Price Prediction 2050
Expect NEO to range from $136.40 to $535.24 through 2050. The $269.01 average target implies a +17.3x move from current prices. That is up +130% on the projected 2040 average. Momentum favours further upside here.
Investment Calculator
Scenario
Investing $1,000 in NEO today (≈ 67.888663 NEO) could be worth
$18,262.8
+$17,262.8 (+1726%) by 2050 · US Dollar
Based on the average projected NEO price of $269.01 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
NEO tools
If You Had Invested in NeoGenomics, Inc.
See what a past investment in NEOwould be worth at today's price.
Invested
$1,000 invested in NEO on Jul 10, 2025 (≈ 169.462452 NEO) would be worth
$2,496.18
+$1,496.18 (+149.6%) today · 2.50× · US Dollar
Based on a NEO entry price of $5.9 vs. today's $14.73.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $15.16 | $971.64 | -2.8% |
| 1 month ago | $11.28 | $1,305.85 | +30.6% |
| 3 months ago | $2.86 | $5,141.59 | +414.2% |
| 6 months ago | $3.94 | $3,739.72 | +274.0% |
| 1 year ago | $5.9 | $2,496.18 | +149.6% |
| All time (5.0y) ago | $45.38 | $324.59 | -67.5% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Will NEO reach a target price?
Enter a price to see how it sits against our NEO forecast.
Likely(2.0× current price)
Our base-case forecast reaches $29.00 around 2030.
Implied market cap at $29.00: $3.78B
NeoGenomics, Inc. Long-Term Forecast (2026–2050)
The multi-year forecast shows a clear upward trajectory in the average price, with notable milestones. The 2026 avg is $14.17 and the 2026 min/max are $7.19 and $22.40, respectively, with an ROI of 0 and a neutral sentiment. By 2030, the avg rises to $24.75 with a max of $38.97 and a min of $17.04, delivering an ROI of 74.7 and a bullish sentiment.
Beyond 2030, the forecast continues to trend higher: 2031 avg $32.55 with ROI 129.7, 2032 avg $40.81 with ROI 188, 2033 avg $46.76 with ROI 230, 2034 avg $48.50 with ROI 242.3, and 2035 avg $48.22 with ROI 240.3, all bullish.
In the long horizon, 2040 shows an avg of $86.47 with a max of $164.56 and an ROI of 510.2, and 2050 projects an avg of $179.00 with a max of $380.51 and an ROI of 1,163.2, maintaining a bullish outlook across the extended horizon.
NEO Frequently Asked Questions
Tap a question to reveal the answer.
What will NeoGenomics be worth in 2030?
The 2030 forecast shows an avg of $24.75 with a min of $17.04 and a max of $38.97, and an ROI of 74.7, with bullish sentiment.
Is NeoGenomics a good investment?
Forecasts indicate a bullish long-term path with rising averages to $24.75 by 2030 and $179.00 by 2050, while near term shows neutral sentiment in 2026 with an avg of $14.17. ROI rises to 74.7% by 2030 and 1,163.2% by 2050, but these are estimates and not guarantees.
Can NeoGenomics reach $100 by 2040?
Yes. The 2040 max is $164.56, which exceeds $100, indicating that the price could surpass $100 by 2040 according to the forecast.
What is NeoGenomics' current price and market cap?
Current price is $14.17 and market capitalization is $1.85B.
What is NeoGenomics' price forecast for 2050?
The 2050 average price is $179.00 with a max of $380.51 and a min of $80.55, with an ROI of 1,163.2 and bullish sentiment.
NeoGenomics, Inc. Community Discussion
0Share your NeoGenomics, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.